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Background
Functional impairment of HDL may contribute to the
excess cardiovascular mortality experienced by patients
with renal disease, but the effect of advanced renal dis-
ease on the composition and function of HDL is not
well understood.
Methods
Mass spectrometry and biochemical analyses were used
to study alterations in the proteome and lipid composi-
tion of HDL isolated from patients on maintenance
hemodialysis.
Results
We identified a significant increase in the amount of
acute-phase protein serum amyloid A1, albumin, lipopro-
tein-associated phospholipase A2, and apoC-III composing
uremic HDL. Furthermore, uremic HDL contained
reduced phospholipids and increased triglycerides and
lysophospholipids. With regard to function, these changes
impaired the ability of uremic HDL to promote cholesterol
efflux from macrophages.
Conclusions
In summary, the altered composition of HDL in renal
disease seems to inhibit the cardioprotective properties
of HDL. Assessing HDL composition and function in
renal disease may help to identify patients at increased
risk for cardiovascular disease.
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